The blinded, randomized clinical trial compares outcomes for spinal fusions between the composite silicon nitride fusion device to PEEK spacers filled with bone autograft.
Amedica’s CASCADE includes a central core of cancellous structured ceramic.
Netherlands-based Mark P. Arts, MD, will present the findings and Amedica Chairman and CEO Sonny Bal, MD, will discuss the study’s potential impact on Amedica’s business.
More articles on orthopedic devices:
Stryker, Medtronic, Zimmer & more—16 key notes
Spine device stock report: 5 key companies
LDR director sells 50k shares—5 key updates
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
